rfmcdonald: (Default)
[personal profile] rfmcdonald
This, obviously, isn't good news.

Strains of mutant HIV emerging in the U.S. and Europe threaten to undermine progress made in expanding access to treatment in poor countries, a study published online by the journal Science found.

About 60 percent of drug-resistant HIV strains circulating in San Francisco can spur self-sustaining epidemics as patients who haven’t been treated spread them, researchers from the University of California, Los Angeles said in the study. Similar trends are emerging in other rich cities including New York, Chicago and London, said Sally Blower, a professor of mathematical biology, who led the research.

Mutant strains are already starting to spread in poorer nations such as South Africa, where there is little access to back-up medicines when resistance develops, Blower said. Newer treatments will likely curb the spread of drug-resistant HIV in San Francisco and other wealthy cities, where patients have better access to alternative treatments, she said.

“If the resistant strains we have identified in our analyses evolve in these countries, they could significantly compromise HIV treatment programs,” Blower and colleagues wrote. Mutant forms “pose a great and immediate threat to global public health,” they said.

The study casts doubt on research by World Health Organization experts published last year that predicted testing everyone for HIV in hard-hit African countries and treating all infections immediately may eliminate most of the virus’s spread. That model, known as “test and treat,” is flawed because it doesn’t take drug resistance into account, Blower said in a telephone interview.
Page generated Jun. 22nd, 2025 10:46 am
Powered by Dreamwidth Studios